Initial analysis of EML4-ALK fusion gene in non-small cell lung cancer

YIN Yongxiang,SHI Shanshan,MA Henghui,CHEN Kai,ZHANG Rusong,ZHOU Xiaojun,WANG Jiandong

DOI: https://doi.org/10.3969/j.issn.1009-0460.2013.09.002

2013-01-01

Chinese Clinical Oncology

Abstract:Objective To investigate the mutation of echinoderm microtubule associated protein like 4-anaplastic lymphoma kinase(EML4-ALK) fusion gene in non-small cell lung cancer( NSCLC),and analyze its mutation with clinicopathologic characteristics and prognosis.Methods Amplification refractory mutation system was used to detect 9 mutations of EML4-ALK fusion gene and 4 mutations including exon 18,19,20 and 21 of epidermal growth factor receptor(EGFR) in 26 patients with NSCLC.The relationship between EML4-ALK mutations and clinicopathologic characters,overall survival(OS) was further analyzed.Results There were 6 patients with EML4-ALK fusion gene mutations out of 26 patients.EML4-ALK fusion gene mutations were not related to pathological types,gender,specimen types and serum carcinoembryonic antigen,but with smoking,age,clinical stage,EGFR mutations and histological differentiation.The median OS of patients with EML4-ALK fusion gene mutations was 9 months,while those without mutations were 12 months(P= 0.460).Conclusion EML4-ALK fusion gene mutations are often found in NSCLC patients with younger age,no history of smoking or a small amount of smoking,later clinical stage,poor histological differentiation and without EGFR mutation.